Sugi Predict

Sugi Predict / Compounds / SCHEMBL6733128

SCHEMBL6733128

SCHEMBL6733128

CS(=O)(=O)c1c(F)cc(-c2cscc2-c2cccc(C(F)(F)F)c2)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 5/20 0.43
▸ AKR1C3 P42330 2/20 0.42
▸ AKR1C2 P52895 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ SLC9A1 P19634 1/20 0.39
▸ ALOX5AP P20292 2/20 0.39
▸ FEN1 P39748 2/20 0.39
▸ RORB Q92753 3/20 0.39
▸ RORC P51449 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ SCN9A Q15858 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ MMP1 P03956 1/20 0.37
▸ MMP2 P08253 1/20 0.37
▸ MMP9 P14780 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6721924 0.86 ALOX5AP (0.46) PTGS2AKR1C3AKR1C2SLC9A1ALOX5AP
SCHEMBL6735699 0.85 PTGS2 (0.49) PTGS2AKR1C3AKR1C2ALOX5APFEN1
SCHEMBL6737135 0.84 PTGS2 (0.47) PTGS2SLC9A1PTGS1
SCHEMBL6736635 0.83 PTGS2 (0.46) PTGS2AKR1C3AKR1C2SLC9A1PTGS1
SCHEMBL6733892 0.82 PTGS2 (0.59) PTGS2PTGS1
SCHEMBL6731830 0.82 PTGS2 (0.45) PTGS2SLC9A1RORBPTGS1
SCHEMBL6733625 0.82 PTGS2 (0.45) PTGS2MAPTALDH1A1PTGS1MAOB
SCHEMBL6734732 0.81 PTGS2 (0.44) PTGS2SCN9APTGS1
SCHEMBL6728404 0.81 RPS6KA3 (0.49) PTGS2ALOX5APFEN1PTGS1
SCHEMBL6739997 0.79 PTGS2 (0.53) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-07-15 — — US disclosed
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 — — US disclosed
US-6673818-B2 TREATING CYCLOOXYGENASE-2 MEDIATED DISORDERS, SUCH AS ARTHRITIS, PAIN, FEVER AND CANCER PHARMACIA CORPORATION 2004-01-06 — — US disclosed
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-08-07 — — US disclosed
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-02-13 — — US disclosed
EP-1251126-A2 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation Pharmacia Corporation (US) 2002-10-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 PTGS2 10/4885AKR1C3 944/4885AKR1C2 1204/4885
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 PTGS2 10/4885AKR1C3 944/4885AKR1C2 1204/4885
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 PTGS2 10/4885AKR1C3 944/4885AKR1C2 1204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.